Clinical Trials in Austin

Showing 7541-7560 of 15,205 trials

Novel Cardiac Signal Processing System

NCT04112433

This study is designed to collect parallel intracardiac signal data during pre-defined periods of clinical interest from the PURE EP system and the existing signal recording and mapping systems. The collected signals will then undergo BLINDED, CONTROLLED evaluation by unbiased electrophysiologist reviewer(s) to determine whether the PURE EP signals provides additional or clearer diagnostic information.

Cardiac Arrhythmia

BioSig Technologies, Inc.104 participantsStarted Nov 2019

Jacksonville, Florida, United States • Boston, Massachusetts, United States • Austin, Texas, United States

COMPLETEDPhase 3< 1 mile

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

NCT00326898

This randomized phase III trial studies sunitinib malate to see how well it works compared to sorafenib tosylate or placebo in treating patients with kidney cancer that has been removed by surgery. Sunitinib malate and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Giving sunitinib malate or sorafenib tosylate after surgery may kill any tumor cells that remain after surgery. It is not yet known whether sunitinib malate is more effective than sorafenib tosylate or placebo in treating kidney cancer.

Clear Cell Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7Stage II Renal Cell Cancer AJCC v7+1 more

National Cancer Institute (NCI)1,943 participantsStarted Apr 2006

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +984 more locations

Novel Cardiac Signal Processing System

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Find Trials by Condition in Austin

S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)

Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis

A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients

ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

Feasibility of Telemedicine Medical Abortion

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Safety Study of MGA271 in Refractory Cancer

Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease